v3.26.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Revenues    
Product revenue, net $ 642 $ 2,266
Operating expenses    
Cost of goods sold 164 2,143
Research and development 30,251 30,435
Selling, general and administrative 20,494 34,492
Restructuring costs 194 2,441
Total operating expenses 51,103 69,511
Loss from operations (50,461) (67,245)
Other (income) expense    
Interest expense 16,984 15,129
Interest income (1,066) (2,602)
Other (income) expense, net 3,518 (20,173)
Net loss $ (69,897) $ (59,599)
Basic net loss per share attributable to common stockholders (in dollars per share) $ (5.73) $ (23.51)
Diluted net loss per share attributable to common stockholders (in dollars per share) $ (5.73) $ (23.51)
Weighted average shares outstanding - basic (in shares) 12,208 2,535
Weighted average shares outstanding - diluted (in shares) 12,208 2,535